Epidemiological studies estimate that nearly nine million people were suffering from active tuberculosis (TB) in 2010, causing upwards of one and a half million deaths. More than 90% of these deaths took place in low- or middle-income countries, thus reinforcing an old idea that TB and poverty are strongly linked.

It seemed appropriate to assemble these texts now, at a time when the history of our AIDS missions is compelling us to formulate new goals. 

Medical Innovations in Humanitarian Situations explores how the particular style of humanitarian action practiced by MSF has stayed in line with the standards in scientifically advanced countries while also leading to significant improvements in the medical care delivered to people in crisis. 

Four hepatitis E epidemics have occurred in the areas in which we operate since 2000, prompting a reflection on the quality of the water produced and distributed to their populations by humanitarian organisations.

Four years after the Nigerian crisis, many things have changed in the nutrition field. This Cahier du Crash aims at considering this evolution and explore new possibilities for action for MSF.

Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations  of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.

Based on MSF's experience in responding to epidemics, Jean-Hervé Bradol describes the risks of spending precious time and energy on trying to delay the spread of the epidemic rather than on the case management of large numbers of sick people.

Humanitarian medicine is intented for marginalized people, hit by a crisis or deprived of access to medical care. This book helps us understand how the specificity of humanitarian medicine stems from real-life situations, more than from the medical act in itself.

Dr. Jean-Hervé Bradol, Former President of MSF-France presented data based on MSF's experience in Niger that showed the implementation of the UN recommendation for the treatment of severe acute malnutrition was not possible in a high burden setting.